InteRNA Technologies provides drug discovery and development services.
InteRNA Technologies secures additional equity financing to progress lead program for melanoma treatmentNijmegen/Utrecht (the Netherlands) – InteRNA Technologies B.V., a biopharma company engaged in the development of microRNA (miRNA)-based therapeutics for oncology, announces today the closing of an equity financing round. New investors participating in this round include the 'Innovation & Investment Fund Gelderland', managed by PPM Oost and several business angels.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Mar 26, 2013 | Series Unknown | — | 1 | Innovation & Investment Fund Gelderland | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Innovation & Investment Fund Gelderland | Yes | Series Unknown |